Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.600
-0.040 (-2.44%)
Feb 11, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Novel Therapeutics
391.70K
Novel Therapeutics Growth
-73.93%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
391.70K
United States Growth
-73.93%